Merck & Co., Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Merck & Co., Inc. (MRK) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$423.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-02-27
- Merck & Co., Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$1.81B.
- Merck & Co., Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $115.00M, a 91.15% decline year-over-year.
- Merck & Co., Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$3.92B.
- Merck & Co., Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $5.19B, a 335.65% increase year-over-year.
- Merck & Co., Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$423.00M.
- Merck & Co., Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$2.01B, a 285.50% decline from fiscal 2015.
- Merck & Co., Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $1.08B.
- Merck & Co., Inc. cash and cash equivalents, period increase (decrease) for fiscal 2014 was -$8.18B, a 476.96% decline from fiscal 2013.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | -$1.81B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$1.69B derived: sum of 2 quarters · filed 2018-02-27 | -$5.62B derived: sum of 3 quarters · filed 2018-02-27 | -$423.00M 10-K · filed 2018-02-27 | ||||
| 2017-09-30 | $115.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$3.81B derived: sum of 2 quarters · filed 2017-11-07 | $1.39B 10-Q · filed 2017-11-07 | -$6.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2017-06-30 | -$3.92B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $1.27B 10-Q · filed 2017-08-08 | -$121.00M derived: sum of 3 quarters · filed 2018-02-27 | $1.18B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2017-03-31 | $5.19B 10-Q · filed 2017-05-09 | $3.80B derived: sum of 2 quarters · filed 2018-02-27 | $5.10B derived: sum of 3 quarters · filed 2018-02-27 | $1.99B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-12-31 | -$1.39B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$93.00M derived: sum of 2 quarters · filed 2018-02-27 | -$3.20B derived: sum of 3 quarters · filed 2018-02-27 | -$2.01B 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | $1.30B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$1.81B derived: sum of 2 quarters · filed 2017-11-07 | -$617.00M 10-Q · filed 2017-11-07 | $359.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | -$3.11B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$1.92B 10-Q · filed 2017-08-08 | -$940.00M derived: sum of 3 quarters · filed 2018-02-27 | -$314.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $1.19B 10-Q · filed 2017-05-09 | $2.17B derived: sum of 2 quarters · filed 2018-02-27 | $2.79B derived: sum of 3 quarters · filed 2018-02-27 | $1.74B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $976.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.60B derived: sum of 2 quarters · filed 2018-02-27 | $544.00M derived: sum of 3 quarters · filed 2018-02-27 | $1.08B 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $626.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$432.00M derived: sum of 2 quarters · filed 2016-11-07 | $107.00M 10-Q · filed 2016-11-07 | -$3.82B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | -$1.06B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$519.00M 10-Q · filed 2016-08-08 | -$4.45B derived: sum of 3 quarters · filed 2017-02-28 | -$2.82B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $539.00M 10-Q · filed 2016-05-09 | -$3.39B derived: sum of 2 quarters · filed 2017-02-28 | -$1.76B derived: sum of 3 quarters · filed 2017-02-28 | -$7.85B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | -$3.93B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$2.30B derived: sum of 2 quarters · filed 2017-02-28 | -$8.39B derived: sum of 3 quarters · filed 2017-02-28 | -$8.18B 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $1.63B derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$4.46B derived: sum of 2 quarters · filed 2015-11-05 | -$4.25B 10-Q · filed 2015-11-05 | -$2.72B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | -$6.08B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$5.88B 10-Q · filed 2015-08-06 | -$4.35B derived: sum of 3 quarters · filed 2016-02-26 | -$5.35B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $207.00M 10-Q · filed 2015-05-07 | $1.74B derived: sum of 2 quarters · filed 2016-02-26 | $738.00M derived: sum of 3 quarters · filed 2016-02-26 | $2.80B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $1.53B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $531.00M derived: sum of 2 quarters · filed 2016-02-26 | $2.60B derived: sum of 3 quarters · filed 2016-02-26 | $2.17B 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | -$1.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $1.07B derived: sum of 2 quarters · filed 2014-11-10 | $639.00M 10-Q · filed 2014-11-10 | -$3.27B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $2.07B derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.64B 10-Q · filed 2014-08-07 | -$2.27B derived: sum of 3 quarters · filed 2015-02-27 | -$1.66B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | -$427.00M 10-Q · filed 2014-05-08 | -$4.34B derived: sum of 2 quarters · filed 2015-02-27 | -$3.73B derived: sum of 3 quarters · filed 2015-02-27 | -$1.63B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | -$3.91B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$3.30B derived: sum of 2 quarters · filed 2015-02-27 | -$1.21B derived: sum of 3 quarters · filed 2015-02-27 | -$80.00M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $608.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $2.70B derived: sum of 2 quarters · filed 2013-11-07 | $3.83B 10-Q · filed 2013-11-07 | $3.11B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-06-30 | $2.10B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $3.22B 10-Q · filed 2013-08-07 | $2.50B derived: sum of 3 quarters · filed 2014-02-27 | $4.41B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-03-31 | $1.13B 10-Q · filed 2013-05-09 | $403.00M derived: sum of 2 quarters · filed 2014-02-27 | $2.31B derived: sum of 3 quarters · filed 2014-02-27 | $2.96B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2011-12-31 | -$722.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $1.19B derived: sum of 2 quarters · filed 2014-02-27 | $1.84B derived: sum of 3 quarters · filed 2014-02-27 | $2.63B 10-K · filed 2014-02-27 | ||||
| 2011-09-30 | $1.91B derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $2.56B derived: sum of 2 quarters · filed 2012-11-09 | $3.35B 10-Q · filed 2012-11-09 | $4.38B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $647.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $1.44B 10-Q · filed 2012-08-07 | $2.47B derived: sum of 3 quarters · filed 2013-02-28 | $3.68B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $795.00M 10-Q · filed 2012-05-08 | $1.82B derived: sum of 2 quarters · filed 2013-02-28 | $3.03B derived: sum of 3 quarters · filed 2013-02-28 | $3.46B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $1.03B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $2.23B derived: sum of 2 quarters · filed 2013-02-28 | $2.66B derived: sum of 3 quarters · filed 2013-02-28 | $1.59B 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $1.21B derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $1.64B derived: sum of 2 quarters · filed 2011-11-08 | $563.00M 10-Q · filed 2011-11-08 | -$11.94B derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2010-06-30 | $430.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | -$645.00M 10-Q · filed 2011-08-08 | -$645.80M 10-Q · filed 2010-08-06 | -$13.15B derived: sum of 3 quarters · filed 2012-02-28 | -$3.79B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2010-03-31 | -$1.07B 10-Q · filed 2011-05-09 | -$1.08B 10-Q · filed 2010-05-07 | -$13.58B derived: sum of 2 quarters · filed 2012-02-28 | -$4.22B derived: sum of 3 quarters · filed 2012-02-28 | $2.22B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2009-12-31 | -$12.51B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$3.15B derived: sum of 2 quarters · filed 2012-02-28 | $3.29B derived: sum of 3 quarters · filed 2012-02-28 | $4.94B 10-K · filed 2012-02-28 | $4.94B 10-K · filed 2010-03-01 | |||
| 2009-09-30 | $9.36B derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $15.80B derived: sum of 2 quarters · filed 2010-11-08 | $17.45B 10-Q · filed 2010-11-08 | $939.00M 10-Q · filed 2009-10-29 | $15.60B derived: sum of 4 quarters · filed 2011-02-28 | |||
| 2009-06-30 | $6.44B derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-06 | $8.09B 10-Q · filed 2010-08-06 | -$384.00M 10-Q · filed 2009-07-24 | $6.24B derived: sum of 3 quarters · filed 2011-02-28 | $6.70B derived: sum of 4 quarters · filed 2011-02-28 | |||
| 2009-03-31 | $1.65B 10-Q · filed 2010-05-07 | -$199.20M derived: sum of 2 quarters · filed 2011-02-28 | $254.80M derived: sum of 3 quarters · filed 2011-02-28 | |||||
| 2008-12-31 | -$1.85B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | -$1.39B derived: sum of 2 quarters · filed 2011-02-28 | -$968.00M 10-K · filed 2011-02-28 | -$967.80M 10-K · filed 2010-03-01 | ||||
| 2008-09-30 | $454.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-29 | $880.00M 10-Q · filed 2009-10-29 | ||||||
| 2008-06-30 | $426.00M 10-Q · filed 2009-07-24 | |||||||
| 2007-12-31 | -$578.60M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |